// App-Quantinova.ai

: Real‐life Anticoagulant Treatment with Edoxaban in Patients with Atrial Fibrillation and Venous Thromboembolism: Aubanalysis of Patient with Creatinine Clearance Greater than 95 ml/min. Experience of 26 Months in Our Centre

Researchers

Presenter

  • M.A. Garcia Ruiz

Principal Investigators

  • P. Romero Garcia

  • E. Morente Constantin

  • M. Rivas Luque

  • G. Salas Camacho

  • M. Jurado Chacon

Medical Centers

  • Hospital Universitario Virgen de las Nieves, Servicio de Hematología y Hemoterapia, Granada, Spain

  • Complejo Asistencial de Soria, Unidad de Cuidados Intensivos, Soria, Spain

  • Hospital Santa Ana, Servicio de Hematología y Hemoterapia, Motril, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

  • Arrhythmia

  • Non-valvular atrial fibrillation

Biomarkers

  • Creatinine

Drug/Treatment

  • Edoxaban

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved